Nancy Ryan Gray
Director at Ligand Pharmaceuticals Inc (LGND)
Nancy Ryan Gray has filed 9 insider reports with the SEC since June 2021, as director at Ligand Pharmaceuticals Inc (LGND). Nancy Ryan Gray made no open-market purchases or sales in the last 12 months. The latest filing, on June 9, 2026, reports grant or award at Ligand Pharmaceuticals Inc (LGND).
- Filings
- 9
- Companies
- 1
- Bought on market
- None
- Sold on market
- $1.43M
Companies where Nancy Ryan Gray is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 8,930 | $1.43M | $286.85 | Jun 9, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 5, 2026LGNDDirector Gray Nancy Ryan was granted 836 shares, increasing direct ownership by 10% to 8,930 unitsForm 4Grant or award
- Nov 7, 2025-$1.35MLGNDDirector Gray Nancy Ryan exercised 6,571 shares at a strike of $69.58 and sold $1,350,012 worth of shares (6,571 units at $205.45)Form 4Exercise or conversion of a derivativeOpen-market sale
- Jun 6, 2025LGNDDirector Gray Nancy Ryan was granted 1,209 shares, increasing direct ownership by 18% to 8,094 unitsForm 4Grant or award
- Jun 14, 2024LGNDDirector Gray Nancy Ryan was granted 1,252 shares, increasing direct ownership by 22% to 6,885 unitsForm 4Grant or award
- May 9, 2024-$77.7KLGNDGray Nancy Ryan sold $77,713 worth of shares (934 units at $83.20), decreasing direct ownership by 14% to 5,633 unitsForm 4Open-market sale
- Jun 9, 2023LGNDSEC Form 4 filed by Gray Nancy RyanForm 4Grant or award
- Dec 22, 2022LGNDSEC Form 4 filed by Gray Nancy RyanForm 4Grant or award
- Jun 10, 2022LGNDSEC Form 4: Gray Nancy Ryan was granted 1,004 shares, increasing direct ownership by 27% to 4,706 unitsForm 4Grant or award
Compare Nancy Ryan Gray with
- Nancy Ryan Gray vs Martine Zimmermann1 shared
- Nancy Ryan Gray vs Jason Aryeh1 shared
- Nancy Ryan Gray vs John W Kozarich1 shared
- Nancy Ryan Gray vs Andrew Reardon1 shared
- Nancy Ryan Gray vs Octavio Espinoza1 shared
- Nancy Ryan Gray vs Jason Haas1 shared
Other insiders at the same companies
- Martine ZimmermannLGND
- Jason AryehLGND
- John W KozarichLGND
- Andrew ReardonLGND
- Octavio EspinozaLGND
- Jason HaasLGND
- Todd C DavisLGND
- Stephen L SabbaLGND
- John L LamattinaLGND
Questions about Nancy Ryan Gray
- What is Nancy Ryan Gray's role at Ligand Pharmaceuticals Inc?
- Nancy Ryan Gray reports to the SEC as director at Ligand Pharmaceuticals Inc (LGND), according to the latest filing on June 9, 2026.
- How many shares does Nancy Ryan Gray own?
- After the latest filing that states it, Nancy Ryan Gray directly owned 8,930 shares of Ligand Pharmaceuticals Inc (LGND). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Nancy Ryan Gray bought or sold stock recently?
- The most recent open-market sale was on November 7, 2025: sold 6,571 shares of Ligand Pharmaceuticals Inc (LGND) for $1.35M at an average of $205.45.
- How do I get alerts when Nancy Ryan Gray files?
- Follow Nancy Ryan Gray on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Nancy Ryan Gray (SEC CIK 0001714949). Totals count each trade once, skipping amendments whose original is on file, from Jun 8, 2021 on. View on SEC EDGAR · Get this as JSON